Overview
Lobbying Costs
9,999€
Financial year: Jan 2016 - Dec 2016
Lobbyists (Full time equivalent)
0.25 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
Pharma Mar, S.A. (PharmaMar)
EU Transparency Register
840804329063-93 First registered on 22 Nov 2017
Goals / Remit
PharmaMar is a company focused on oncology and committed to research and development which takes inspiration from the sea to discover molecules with antitumor activity. We are an integrated company that seeks innovative products to provide healthcare professionals with new tools to treat cancer.
PharmaMar’s commitment to patients and to research has made it a world leader in the discovery of antitumor drugs of marine origin.Main EU files targeted
Política de investigación
EMA
Financiación a la investigación y desarrolloAddress
Head Office
Av. de los Reyes, 1
Colmenar Viejo
MADRID 28770
SPAIN -
People
Total lobbyists declared
1
Employment time Lobbyists 25% 1 Lobbyists (Full time equivalent)
0.25
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Carmen Guijarro EIBE (Directora Dpto. Coordinación Proyectos)
Person with legal responsibility
JOSE MARIA FERNANDEZ SOUSA-FARO (Presidente)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
None declared
Member organisations
None declared
-
Financial Data
Closed financial year
Jan 2016 - Dec 2016
Lobbying costs for closed financial year
9,999€
EU grant income for closed financial year
178,747 € (Source: EU Fund)
Other financial info
None declared
-
EU Structures
Groups (European Commission)
EBE
ACC
None
Groups (European Parliament)
None
Communication activities
Horizon2020
Drug Approval proceduresOther activities
None declared
- Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 24 Nov 2017 Location Brussels Subject Pharmaceutical policy Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
Other Lobbyists
- Meetings